e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Studies on the mechanisms underlying airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterisation of a chronic pre-clinical model of allergic asthma
P. Flajolet (London, United Kingdom), J. De Alba (London, United Kingdom), K. Raemdonck (London, United Kingdom), M. Belvisi (London, United Kingdom), M. Birrell (London, United Kingdom)
Source:
International Congress 2018 – Studies on the mechanisms underlying airway disease
Session:
Studies on the mechanisms underlying airway disease
Session type:
Thematic Poster
Number:
4413
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Flajolet (London, United Kingdom), J. De Alba (London, United Kingdom), K. Raemdonck (London, United Kingdom), M. Belvisi (London, United Kingdom), M. Birrell (London, United Kingdom). Characterisation of a chronic pre-clinical model of allergic asthma. 4413
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Development of an integrated allergic rhinitis and asthma model with partial immunological tolerance
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Characterization of CD4-endotypes in severe allergic asthma for future precision medicine
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001
Comparative analysis of allergic and non-allergic severe persistent asthma
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005
Analysis of mucus production in mouse models of allergic asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 360s
Year: 2007
Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008
Regular and moderate exercise prevents airway remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011
Identifying eosinophil subsets in a mouse model of pollutant-aggravated allergic asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
Clinical and experimental investigation of patients with allergic rhinitis and animal models
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008
Development of a novel prediction model for acute asthma exacerbation
Source: International Congress 2018 – Asthma management
Year: 2018
Small airways dysfunction: the link between allergic rhinitis and allergic asthma
Source: Eur Respir J, 51 (2) 1701749; 10.1183/13993003.01749-2017
Year: 2018
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept